BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $62,000 | -89.3% | 10,040 | -87.3% | 0.04% | -88.7% |
| Q2 2018 | $582,000 | +17.1% | 78,945 | +4.3% | 0.35% | +18.5% |
| Q1 2018 | $497,000 | -19.3% | 75,722 | +3.4% | 0.30% | -17.2% |
| Q4 2017 | $616,000 | -39.4% | 73,232 | -16.8% | 0.36% | -37.1% |
| Q3 2017 | $1,017,000 | +5.0% | 88,072 | +6.1% | 0.57% | +7.7% |
| Q2 2017 | $969,000 | -6.1% | 82,997 | -0.7% | 0.53% | -10.5% |
| Q1 2017 | $1,032,000 | +184.3% | 83,622 | +390.5% | 0.59% | +263.8% |
| Q2 2015 | $363,000 | -7.6% | 17,050 | +0.6% | 0.16% | -4.1% |
| Q1 2015 | $393,000 | – | 16,950 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |